1. Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
   Panagiota Papanagnou et al, 2016, Pharmaceuticals CrossRef
2. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis
   Hong Wang et al, 2017, Molecules CrossRef
3. Concentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells
   Silvia Ravera et al, 2018, J Cell Physiol CrossRef
4. Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells
   ID Turacli et al, 2017, Hum Exp Toxicol CrossRef
5. Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells
   Mei Xiang et al, 2017 CrossRef
6. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus
   Chin-Hsiao Tseng, 2018, Metabolism CrossRef
7. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells
   Ming Wang et al, 2017, Cancer Biotherapy and Radiopharmaceuticals CrossRef
8. Senolytics and senostatics as adjuvant tumour therapy
   Susan Short et al, 2019, EBioMedicine CrossRef
9. Metformin influences progression in diabetic glioblastoma patients
   Sebastian Adeberg et al, 2015, Strahlenther Onkol CrossRef
10. Radiation-Induced Glycogen Accumulation Detected by Single Cell Raman Spectroscopy Is Associated with Radioresistance that Can Be Reversed by Metformin
    Quinn Matthews et al, 2015, PLoS ONE CrossRef
11. Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy
    Xuejiao Song et al, 2017, Nano Res. CrossRef
12. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach
    Athanasia Pavlopoulou et al, 2017, Cancer Letters CrossRef
13. Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy
    Jinping Wang et al, 2019, Adv. Therap. CrossRef
14. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition
    Ke-Fen Zhang et al, 2019, J Can Res Ther CrossRef
15. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams
    Eun Ho Kim et al, 2016, Oncotarget CrossRef
16. Transcriptomic landscape profiling of metformin-treated healthy mice: Implication for potential hypertension risk when prophylactically used
    Yuhong Meng et al, 2020, J Cell Mol Med CrossRef
17. Metformin: (future) best friend of the radiation oncologist?
    Benjamin Chevalier et al, 2020, Radiotherapy and Oncology CrossRef
18. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
    Zhongwei Chen et al, 2021, Sci Rep CrossRef
19. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
    Mirian Galliote Morale et al, 2022, Biomolecules CrossRef
20. Combined regimens of cisplatin and metformin in cancer therapy: A systematic review and meta-analysis
    Emad Jafarzadeh et al, 2022, Life Sciences CrossRef
21. Metformin Sensitizes Cisplatin-induced Apoptosis Through Regulating Nucleotide Excision Repair Pathway In Cisplatin-resistant Human Lung Cancer Cells
    Haiwen Li et al, 2022, LDDD CrossRef
22. Senotherapy as a Novel Therapeutic Method in Cancer Treatment: With a Focus on Head and Neck Cancer
    Heliya Ziaei et al, 2023 CrossRef
23. The Association between Metformin and the Cancer-Specific Mortality Rate in Nasopharyngeal Cancer Patients: Real-World Evidence
    Yen Hsu et al, 2023, Current Oncology CrossRef
24. Repurposing Metformin in hematologic tumor: State of art
    Min Hu et al, 2023, Current Problems in Cancer CrossRef
25. Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1
    Mariangela Palazzo et al, 2024, Pathologica CrossRef
26. Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
    Wenting Li et al, 2025, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef